Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06550245 · ClinicalTrials.gov registry record

Babies' Brain Responses to Strangers

A clinical trial of Infant Development, sponsored by University of California Santa Cruz.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06550245: Recruiting study of Infant Development, sponsored by University of California Santa Cruz.

NCT06550245 is a study of Infant Development that is actively recruiting participants, run by University of California Santa Cruz. The registered enrollment target is 100 participants, below the 400-participant average among 30 other Infant Development trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06550245, a study of Infant Development, is actively recruiting participants, sponsored by University of California Santa Cruz.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Researchers at the Diversity in Development Lab at UC Santa Cruz are investigating how babies' brain activities respond to people from familiar and unfamiliar racial backgrounds.

Primary Outcome

EEG oscillation in alpha power over central regions

Conditions Studied

Interventions

  • OTHER Infants observing familiar and unfamiliar racial groups

Study Locations (1)

California

  • Social Science 2 Building - Santa Cruz

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-07-23
Est. Completion 2025-10

What NCT06550245 shows while recruiting

NCT06550245 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 400-participant average among 30 other Infant Development trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Infant Development appearing as the primary indexed condition, and to 1 intervention - of which Infants observing familiar and unfamiliar racial groups is the first listed.

NCT06550245 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06550245 about?

NCT06550245 is a clinical study titled "Babies' Brain Responses to Strangers". Researchers at the Diversity in Development Lab at UC Santa Cruz are investigating how babies' brain activities respond to people from familiar and unfamiliar racial backgrounds.

What is the current status of trial NCT06550245?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-07-23. Estimated completion is 2025-10.

What conditions does trial NCT06550245 study?

This clinical trial studies the following conditions: Infant Development.

What interventions are being tested in trial NCT06550245?

The interventions under investigation include: Infants observing familiar and unfamiliar racial groups (OTHER).

Who is sponsoring clinical trial NCT06550245?

This trial is sponsored by University of California Santa Cruz, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06550245 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06550245's enrollment target sits among peer trials

100 18th of 30 higher than 12 of 30 other Infant Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06550245, the US trial registry maintained by the National Library of Medicine. NCT06550245 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.